Vol. 123, No. 1 (Supplement) 2018
Supplement abstract

Effects of Pleurotus eryngii var. eryngii in “in vitro” and “in vivo” cancerogenetic models

Francesca Rappa
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Rosario Barone
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Maria Letizia Gargano
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Celeste Caruso Bavisotto
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Felicia Farina
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Filippo Macaluso
SMART Engineering Solutions & Technologies (SMARTEST) research center, eCampus University, Novedrate (CO), Italia
Claudia Campanella
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Daniela D’Amico
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Eleonora Trovato
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Valentina Di Felice
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Francesco Cappello
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia
Giuseppe Venturella
Dipartimento di scienze agricole e forestali, Università degli studi di Palermo, Palermo, Italia
Antonella Marino Gammazza
Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università degli Studi di Palermo, Palermo, Italia

Published 2018-12-30

Keywords

  • Hsp60,
  • Pleurotus eryngii,
  • cancer

How to Cite

Rappa, F., Barone, R., Gargano, M. L., Caruso Bavisotto, C., Farina, F., Macaluso, F., Campanella, C., D’Amico, D., Trovato, E., Di Felice, V., Cappello, F., Venturella, G., & Marino Gammazza, A. (2018). Effects of Pleurotus eryngii var. eryngii in “in vitro” and “in vivo” cancerogenetic models. Italian Journal of Anatomy and Embryology, 123(1), 178. https://doi.org/10.13128/ijae-11498

Abstract

Heat shock proteins (Hsps) are highly expressed in a variety of cancer types contributing to tumor cell propagation and protection against apoptosis [1]. The current anti-cancer thera- py is not always target specific and often is associated with complications for patients, There- fore new effective, specific and less toxic therapeutic approaches are needed. Medicinal mush- rooms have emerged as wonderful source of nutraceuticals, anti-oxidants, anticancer, prebi- otic, anti-inflammatory, cardiovascular, anti-microbial, and anti-diabetic. The ongoing research projects are aimed to promote mushrooms as new generation ‘‘biotherapeutics’’ [2]. The aim of this study was to evaluate whether the cold-water extracts of Pleurotus eryngii var. eryn- gii can affect Hsp90, 70, 60 and 27 levels in an in vitro model of colon cancer (C26 cells). Cell viability was evaluated using MTT assay after treating the cells with different concentrations of extracts (0-1.9 μg/μl) in the culture medium for 24 and 48 hours. Hsp90, 70, 60 and 27 levels were measured using western blotting and immunofluorescence analysis. Moreover, we evalu- ated the anticancer effect of the P. eryngii var. eryngii extract in an animal model of ectopically- implanted C26 colon carcinoma, widely used as an experimental model of cancer cachexia. We prepared a mixture of lyophilized P. eryngii var. eryngii with the mice standard diet and the animals were daily fed with ~4g of the mix until they died to draw a survival curve. We sam- pled the neoformations grown after implantation e on these we performed an immunohisto- chemistry for Hsp60. Our results showed that the extract significantly decreased cells viability at 0.48 μg/μl after both 24 and 48 hours of treatments. Western blotting analysis and immu- nofluorescence showed that Hsp60 protein levels were down-regulate at 24h of treatment but increased after 48h. On the contrary, Hsp90, 70 and 27 protein levels did not changed. In the in vivo model, P. eryngii var. eryngii in the diet significantly extended the median survival com- pared to untreated mice. The immunoistochemical experiments suggested that Pleuery signifi- cantly affected the increase of Hsp60 protein levels. These preliminary results are promising for further studies to better understand the potential effects of P. eryngii var. eryngii on cancer pro- gression especially regarding Hsp60 role.

Metrics

Metrics Loading ...